Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
AbstractAlthough there have been many pharmacological agents considered to be neuroprotective therapy in Parkinson’s disease (PD) patients, neurosurgical approaches aimed to neuroprotect or restore the degenerative nigrostriatal system have rarely been the focus of in depth reviews. Here, we explore the neuroprotective strategies involving invasive surgical approaches (NSI) using neurotoxic models 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6-hydroxydopamine (6-OHDA), which have led to clinical trials. We focus on several NSI approaches, namely deep brain stimulation of the subthalamic nucleus, glial neurotrophic derived factor (GDNF) administration and cell grafting methods. Although most of these interventions have produced positive results in preclinical animal models, either from behavioral or histological studies, they have generally failed to pass randomized clinical trials to validate each approach. We argue that NSI are promising approaches for neurorestoration in PD, but preclinical studies should be planned carefully in order not only to detect benefits but also to detect potential adverse effects. Further, clinical trials should be designed to be able to detect and disentangle neuroprotection from symptomatic effects. In summary, our review study evaluates the pertinence of preclinical models to study NSI for PD and how this affects their efficacy when translated into clinical trials. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 119 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Torres, N.; Molet, J.; Moro, C.; Mitrofanis, J.; Benabid, A.L. Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data. Int. J. Mol. Sci. 2017, 18, 2190.
Torres N, Molet J, Moro C, Mitrofanis J, Benabid AL. Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data. International Journal of Molecular Sciences. 2017; 18(10):2190.Chicago/Turabian Style
Torres, Napoleon; Molet, Jenny; Moro, Cecile; Mitrofanis, John; Benabid, Alim L. 2017. "Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data." Int. J. Mol. Sci. 18, no. 10: 2190.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.